- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00927849
Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy
May 7, 2009 updated by: Mansoura University
Idiopathic hypertensive anal canal is a fact and already exists presented by anal pain aggravated by defecation.
It can be managed safely by closed lateral sphincterotomy but chemical sphincterotomy had a minor role in its management.
Study Overview
Status
Completed
Conditions
Detailed Description
Patient and methods: Sixty three patients complaining of anal pain without any anal pathology and 10 healthy volunteers were examined.
All patients underwent clinical evaluation, neurological examination, anorectal manometry, and measurement of pudendal nerve terminal motor latency (PNTML).
All patients with hypertensive anal canal were randomized into three groups.
Group I (surgical group) underwent closed lateral sphincterotomy LS, group II using nitroglycerine ointment (GTN) and group III received injection of botulinum toxin in internal sphincter.
Post procedures data were recorded at follow up period.
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mansoura, Egypt, 335111
- Ayman Elnakeeb
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 61 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- all patients with hypertensive anal canal
Exclusion Criteria:
- patients who had any pathological anorectal lesions such as anal fissure, piles, rectal prolapse, intussusception, anismus, cancer, patients with normal anal pressure
- patients who previously had anorectal surgery, chemical or surgical sphincterotomy, anal dilatation, IBD, venereal disease, neurological disorder or systemic gastrointestinal disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: surgical group lateral sphincterotomy
underwent closed lateral internal sphincterotomy (LIS) under local anesthesia at 3 o'clock in lithotomy position reaching up to the dentate line.
|
closed lateral internal sphincterotomy was done under local anesthesia at 3 o'clock in lithotomy position reaching up to the dentate line.
|
Active Comparator: Glycerin trinitrate group
all were instructed to apply the Glycerin trinitrate group (GTN) ointment 0.2 % twice a day to the edge and just inside the anal canal for 8 week course.
|
All were instructed to apply the GTN ointment 0.2 % twice a day to the edge and just inside the anal canal for 8 week course.
Other Names:
|
Active Comparator: botulinum toxin injection
All were injected with botulinum toxin injection (BTX- A) in the left lateral position; anesthesia was not required.
A volume of 0.5 ml of dissolved toxin, i.e., 100 u Dysport, is injected in each patient.
The injection is given with an insulin syringe fitted with a needle size of 21 gauze and 3.75 lengths.
Injection into the IAS, with the patients awake in the left -lateral position in the outpatient clinic in the 3 and 9 o'clock position.
|
All were injected with botulinum toxin injection (BTX- A) in the left lateral position; anesthesia was not required.
A volume of 0.5 ml of dissolved toxin, i.e., 100 u Dysport, is injected in each patient.
The injection is given with an insulin syringe fitted with a needle size of 21 gauze and 3.75 lengths.
Injection into the IAS, with the patients awake in the left -lateral position in the outpatient clinic in the 3 and 9 o'clock position.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of Closed Lateral Sphincterotomy and Chemical Sphincterotomy on Hypertensive Anal Canal
Time Frame: one year
|
effect of closed lateral sphincterotomy and chemical sphincterotomy on hypertensive anal canal, anal manometery
|
one year
|
Relieve of Anal Pain
Time Frame: one year after the procedure
|
using a visual analog scale (VAS) with which each patients noted the severity of pain at each evaluated time using a linear between zero (no pain) and 10 ( severe pain)
|
one year after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ayman Elnakeeb, MD, Mansoura University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Aysan E, Aren A, Ayar E. A prospective, randomized, controlled trial of primary wound closure after lateral internal sphincterotomy. Am J Surg. 2004 Feb;187(2):291-4. doi: 10.1016/j.amjsurg.2003.11.011.
- Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med. 1999 Jul 8;341(2):65-9. doi: 10.1056/NEJM199907083410201. Erratum In: N Engl J Med 1999 Aug 19;341(8):624.
- Orsay C, Rakinic J, Perry WB, Hyman N, Buie D, Cataldo P, Newstead G, Dunn G, Rafferty J, Ellis CN, Shellito P, Gregorcyk S, Ternent C, Kilkenny J 3rd, Tjandra J, Ko C, Whiteford M, Nelson R; Standards Practice Task Force; American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissures (revised). Dis Colon Rectum. 2004 Dec;47(12):2003-7. doi: 10.1007/s10350-004-0785-7. No abstract available.
- Neill ME, Swash M. Chronic perianal pain: an unsolved problem. J R Soc Med. 1982 Feb;75(2):96-101. doi: 10.1177/014107688207500205.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2002
Primary Completion (Actual)
April 1, 2008
Study Completion (Actual)
May 1, 2008
Study Registration Dates
First Submitted
March 23, 2009
First Submitted That Met QC Criteria
May 7, 2009
First Posted (Estimate)
June 25, 2009
Study Record Updates
Last Update Posted (Estimate)
June 25, 2009
Last Update Submitted That Met QC Criteria
May 7, 2009
Last Verified
May 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- hypertensive anal canal
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertensive Anal Canal
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingAnal Squamous Cell Carcinoma | Anal Basaloid Carcinoma | Anal Canal Cloacogenic Carcinoma | Metastatic Anal Canal Carcinoma | Recurrent Anal Canal Carcinoma | Stage IIIB Anal Canal Cancer | Stage IV Anal Canal CancerUnited States
-
Sun Yat-sen UniversityEnrolling by invitationAnal Canal Cancer | Anal Squamous Cell Carcinoma | Anal Cancer | Anal Canal Cancer Stage I | Anal Canal Cancer Stage II | Anal Canal Cancer Stage IIIChina
-
National Cancer Institute (NCI)Active, not recruitingAnal Canal Squamous Cell Carcinoma | Metastatic Anal Canal Carcinoma | Stage IV Anal Canal Cancer AJCC v6 and v7United States, Canada
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingAnal Canal Cancer | Anal Squamous Cell Carcinoma | Anal Cancer | Anal Canal Cancer Stage IIIChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingAnal Basaloid Carcinoma | Anal Canal Cloacogenic Carcinoma | Anal Canal Squamous Cell Carcinoma | Anal Margin Squamous Cell Carcinoma | Stage I Anal Cancer AJCC v8 | Stage IIA Anal Cancer AJCC v8United States
-
AHS Cancer Control AlbertaUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedHigh Grade Anal Canal Intraepithelial Neoplasia | High Grade Vulvar Squamous Intraepithelial LesionUnited States
-
Institut Cancerologie de l'OuestCompletedCervical Cancer | Prostate Cancer | Anal Canal CancersFrance
-
Dr. Te VuongYM BioSciencesTerminatedSquamous Cell Carcinoma of Anal CanalCanada
-
Centre Francois BaclesseAccuray IncorporatedActive, not recruitingLocally Advanced Anal Canal CancerFrance
Clinical Trials on lateral internal sphincterotomy (LIS)
-
Mansoura UniversityCompleted
-
Sheba Medical CenterNot yet recruiting
-
Mansoura UniversityCompletedPain | Haemorriodectomy | Anal SphincterotomyEgypt
-
Mansoura UniversityCompleted
-
Zagazig UniversityCompletedChronic Anal FissureEgypt
-
Mansoura UniversityCompleted
-
State Scientific Centre of Coloproctology, Russian...Recruiting
-
Hvidovre University HospitalUnknownFocus: Anal Incontinence After Lateral Sphincterotomy for Chronic Anal FissureDenmark
-
Theodor Bilharz Research InstituteCompleted
-
Masarykova Nemocnice v Usti nad Labem, Krajska...CompletedCentral Vein CatheterCzechia